Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) EBIT Margin (2016 - 2025)

Bio Key International (BKYI) has disclosed EBIT Margin for 16 consecutive years, with 57.57% as the latest value for Q3 2025.

  • Quarterly EBIT Margin fell 3051.0% to 57.57% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 61.5% through Sep 2025, up 1347.0% year-over-year, with the annual reading at 57.88% for FY2024, 5593.0% up from the prior year.
  • EBIT Margin hit 57.57% in Q3 2025 for Bio Key International, up from 63.87% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 23.33% in Q1 2024 to a low of 284.13% in Q4 2022.
  • Historically, EBIT Margin has averaged 102.07% across 5 years, with a median of 80.52% in 2023.
  • Biggest five-year swings in EBIT Margin: skyrocketed 34813bps in 2021 and later tumbled -9532bps in 2022.
  • Year by year, EBIT Margin stood at 213.85% in 2021, then crashed by -33bps to 284.13% in 2022, then skyrocketed by 47bps to 149.24% in 2023, then surged by 42bps to 86.69% in 2024, then soared by 34bps to 57.57% in 2025.
  • Business Quant data shows EBIT Margin for BKYI at 57.57% in Q3 2025, 63.87% in Q2 2025, and 39.86% in Q1 2025.